122 related articles for article (PubMed ID: 7963743)
1. Vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer.
Borja J; Gratacós L; García-Barbal J
J Infect Dis; 1994 Nov; 170(5):1344-5. PubMed ID: 7963743
[No Abstract] [Full Text] [Related]
2. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
Sidi V; Roilides E; Bibashi E; Gompakis N; Tsakiri A; Koliouskas D
J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
[TBL] [Abstract][Full Text] [Related]
3. Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: microbiological, clinical and economic evaluation.
D'Antonio D; Staniscia T; Piccolomini R; Fioritoni G; Rotolo S; Parruti G; Di Bonaventura G; Manna A; Savini V; Fiorilli MP; Di Giovanni P; Francione A; Schioppa F; Romano F
Chemotherapy; 2004 Jun; 50(2):81-7. PubMed ID: 15211082
[TBL] [Abstract][Full Text] [Related]
4. A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer.
Rolston KV; Nguyen H; Amos G; Elting L; Fainstein V; Bodey GP
J Infect Dis; 1994 Feb; 169(2):350-5. PubMed ID: 8106768
[TBL] [Abstract][Full Text] [Related]
5. Enterococcus faecium sensitive to teicoplanin but not vancomycin.
Wilson AP; Felmingham D; Robbins M; Chopra R
J Hosp Infect; 1991 Aug; 18(4):322-4. PubMed ID: 1682372
[No Abstract] [Full Text] [Related]
6. [Therapy of resistant gram-positive infection: value of glycopeptide antibiotics vancomycin and teicoplanin].
Waldvogel F
Schweiz Med Wochenschr; 1993 Dec; 123(50):2353-6. PubMed ID: 8272810
[No Abstract] [Full Text] [Related]
7. Infective endocarditis and glycopeptides.
Pittet D; Harding I
J Infect; 1998 Sep; 37(2):127-35. PubMed ID: 9821086
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of ramoplanin (a novel lipoglycopeptide), vancomycin, and teicoplanin against gram-positive clinical isolates from cancer patients.
Rolston KV; Dholakia N; Ho DH; LeBlanc B; Dvorak T; Streeter H
J Antimicrob Chemother; 1996 Aug; 38(2):265-9. PubMed ID: 8877541
[TBL] [Abstract][Full Text] [Related]
9. [Vancomycin and teicoplanin: differential aspects].
Cobo J
Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):600-10. PubMed ID: 8808477
[No Abstract] [Full Text] [Related]
10. Treatment of Peptostreptococcus micros endocarditis with teicoplanin.
Wenisch C; Wiesinger E; Werkgartner T; Makristathis A; Graninger W
Clin Infect Dis; 1995 Aug; 21(2):446-7. PubMed ID: 8562764
[No Abstract] [Full Text] [Related]
11. [Teicoplanin. New treatment potentials for gram-positive infections in the hospital].
Iakovlev SV
Antibiot Khimioter; 1999; 44(2):3-7. PubMed ID: 10202550
[No Abstract] [Full Text] [Related]
12. A therapeutic benefit of daptomycin against glycopeptide-resistant gram-positive cocci bloodstream infections under neutropenia.
Matsuda K; Koya J; Toyama K; Ikeda M; Arai S; Nakamura F; Okugawa S; Moriya K; Kurokawa M
J Infect Chemother; 2017 Nov; 23(11):788-790. PubMed ID: 28743428
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of teicoplanin in the treatment of gram-positive bacterial intravascular infections.
Livornese LL; Gold M; Johnson CC; Measley R; Kaye D; Korzeniowski O; Walsh ML; Samel C; Hessen M; Levison ME
J Antimicrob Chemother; 1993 Jan; 31(1):188-91. PubMed ID: 8444670
[No Abstract] [Full Text] [Related]
14. The role of teicoplanin in the treatment of febrile neutropenia.
Menichetti F
J Chemother; 2000 Nov; 12 Suppl 5():34-9. PubMed ID: 11131962
[TBL] [Abstract][Full Text] [Related]
15. Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.
Spencer CM; Bryson HM
Pharmacoeconomics; 1995 Apr; 7(4):357-74. PubMed ID: 10155323
[TBL] [Abstract][Full Text] [Related]
16. [First case of infection due to vancomycin resistant Enterococcus faecalis in New Caledonia].
Garin B; Barny S; Lechevallier S; Agathe-Nerine J
Med Mal Infect; 2006 May; 36(5):297-8. PubMed ID: 16631333
[No Abstract] [Full Text] [Related]
17. [Retrospective analysis of the Gram-positive bacteria-infected cases in the Department of Hematology].
Jing Y; Bo J; Zhao Y; Li HH; Wang SH; Huang WR; Wang QS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1291-5. PubMed ID: 24156452
[TBL] [Abstract][Full Text] [Related]
18. What do I need to know about glycopeptide antibiotics?
Li S; Starkey ES
Arch Dis Child Educ Pract Ed; 2016 Dec; 101(6):323-326. PubMed ID: 27389546
[TBL] [Abstract][Full Text] [Related]
19. Teicoplanin.
Shea KW; Cunha BA
Med Clin North Am; 1995 Jul; 79(4):833-44. PubMed ID: 7791426
[TBL] [Abstract][Full Text] [Related]
20. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ
Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
